What DSCSA compliance actually costs an independent pharmacy

Pricing in this category is mostly hidden, and that is the first thing worth naming. Of the organisations an independent pharmacy is most likely to reach when it searches for DSCSA help, only one publishes a number at all. So a page that claims to compare the cost of DSCSA compliance is usually either quoting one vendor or inventing the rest. This page quotes only numbers that were on the vendor’s own site when it was last checked, every source below was re-retrieved on 7 August 2026, and says plainly where a number does not exist.

One of those numbers changed between checks, and this page changed with it. Until 5 August 2026 the DSCSA360 product page carried the line “Sign-up for as low as $66/month.” On 7 August 2026 that sentence was gone and the page contained no dollar figure at all, saying instead that PRS and Advasur had built “the most convenient and complete DSCSA solution at an affordable price.” The actual fee table had moved to the sign-up portal the page links to. The numbers below are the ones on that portal today, and the old figure is named here rather than quietly deleted, because a pharmacy that read this page last week budgeted against it.

Who actually prepares DSCSA documentation for a pharmacy

Six different kinds of organisation answer that question, and the price shape follows the kind. Who can prepare DSCSA documentation for your pharmacy takes all six one at a time, including when the right answer is a lawyer rather than any of the options priced here.

• Your own trade associations, for nothing. DispenserEDU publishes free educational material on implementing the DSCSA. It sells nothing and prepares nothing.
• Track-and-trace platforms. InfiniTrak and LSPedia move, host and reconcile serialized transaction data. Neither publishes a price. We compare that category against a written record in detail.
• Compliance programs for pharmacies. PRS Pharmacy Services sells DSCSA360, a program it now delivers in partnership with Advasur, which bundles the written material and the data feed into one ongoing subscription. It is the only paid option here with a published fee table.
• Pharmacy-only DSCSA platforms. Advasur sells Advasur 360 to pharmacies alone, receipt and reconciliation of transaction records, a missing-data workflow, training, six-year retention and retrieval. It publishes no price and enters through a 30-minute readiness review. We set that category beside the other five.
• Healthcare regulatory attorneys. Oberheiden P.C. and firms like it will implement “policies, procedures, and protocols designed to ensure strict DSCSA compliance.” No fee is published, and the reason to pay one is usually not the documents themselves, it is privilege, or an inspection that has already started.
• Documentation preparation. DoseTrace prepares the binder itself and stops there. One fixed fee, no platform.

The two published numbers

PRS Pharmacy Services describes itself as “Trusted Experts in Pharmacy Compliance, Brokerage, Staffing, and Consulting for Independent Pharmacies,” and its DSCSA360 program, “Created by Pharmacists for Pharmacies”, is now delivered with Advasur: “PRS and Advasur have partnered to provide DSCSA 360™.” For the subscription, its own page lists an “Easy to follow Compliance Guide,” “Required Policies and Procedures/SOPs,” “Required forms,” employee training on the software and SOPs, alerts for suspect data, recalls and expiring trading-partner credentials, EPCIS transaction data from authorized trading partners on one website, and “DSCSA Audit assistance is available at no cost.”

The product page itself no longer names a price. The fees are published in Attachment B of the service agreement on the sign-up portal that page links to, under the heading “SERVICE MONTHLY FEE TABLE”, and they are charged per pharmacy location, the agreement states the dispenser “is responsible for purchasing programs/products for use at each individual location (based on street address and/or separate State Pharmacy License)” and that products “are not permitted to be shared among Pharmacy locations.”

The table gives no condition for the discounted column; the portal’s sign-up form asks which buying group the pharmacy belongs to, from a list of around forty. There is also a one-off item underneath the subscription: if the pharmacy has no Global Location Number, PRS will obtain and maintain one, and “the cost of obtaining a GLN is $50.”

That is a broader offering than ours, and it would be dishonest to present it otherwise. It covers both halves of the problem, the written record and the ongoing data feed, where DoseTrace covers only the first.

DoseTrace is $99 flat, one time, from a 15-minute intake: the nine-document readiness binder, each document dated. No subscription, no per-store multiplier, no integration, and no data feed.

The free option, and the line where it stops

Before paying anyone, a pharmacy should know that a free resource exists and who is behind it. DispenserEDU describes itself as “A resource page developed collaboratively among supply chain trading partners to house educational information dispensers may find useful to assist in implementation of the DSCSA,” and identifies those partners by carrying their logos: APhA, ASHP, HDA, NABP, NCPA, PDG and PDSA. That is the pharmacy profession’s own associations and the distributor and standards bodies, not a company with something to sell. It publishes no price because it charges nothing.

The line is the difference between reading about the requirement and holding a record of having met it. Educational material explains what §582 asks for; it cannot contain your pharmacy’s exemption determination, your dated SOPs, your named trading partners or your staff’s training attestations, because none of those facts are known to it. An inspector does not ask what you have read. Every pharmacy should start at DispenserEDU. Some will finish there, write the nine documents themselves, and owe nobody anything, that is a real outcome and this page is not going to pretend otherwise. Paying $99 buys the writing time, not the knowledge.

Recurring versus one-time, with the arithmetic shown

A single-location community pharmacy at the discounted $83/month pays $996over twelve months, and at the standard $115/month pays $1,380. Both recur: a second year is another $996 or $1,380, a third another. Because the fee is charged per location, a three-store owner at the discounted rate is at $2,988 a year. DoseTrace’s $99 is paid once, covers the pharmacy rather than the store count, and does not renew.

That arithmetic is not the argument, though, and it would be a cheap one to make: the subscription buys something the one-time fee does not buy at all. The comparison people usually want, which is cheaper, has no clean answer, because the two prices do not buy the same thing. The comparison that is actually decidable is this: is your gap a one-time gap or a continuing one? A missing set of SOPs, a missing exemption determination and a missing training attestation are one-time gaps. They get written once and maintained. A wholesaler data feed that has to keep arriving, keep being monitored for suspect product and keep flagging recalls is a continuing service, and a continuing service is correctly priced as a subscription. Paying a subscription for a one-time gap means paying for the same finished documents every month. Paying a one-time fee for a continuing need leaves the continuing need unmet.

What neither number includes

Nothing on this page is the cost of the compliance itself, the staff hour spent scanning an incoming order, the pharmacist time reading a suspect-product alert, the wholesaler portal you already pay for inside your primary contract. Those sit underneath every option here and do not disappear with any of them.

The expensive mistake is upstream of the price

Before comparing any of these numbers, confirm which exemption track you are on, because it changes what you are buying and when. The FDA’s small-business-dispenser exemption now runs until 27 November 2027, extended by a year on 6 August 2026, and it reaches a pharmacy only if the corporate entity that owns it has 25 or fewer full-time pharmacists and qualified technicians, counted across the whole company, not per store, and counted on one fixed day rather than continuously. That day is 27 November 2024 for the window running now and 27 November 2026 for the extra year. PRS’s own page points at the earlier instrument, describing “the exemption announced on 6/12/2024”, a reminder that vendor pages in this market lag the letters, and that a quote written against a superseded date is worth questioning before it is worth paying.

The extension is a reason to buy more carefully, not a reason to buy nothing. Fifteen months is enough time to compare a $99 one-off against a recurring per-location fee properly, and it is also long enough for a subscription started today to cost more before the deadline than it would have over the old window. Price the thing against the date that now applies.

If your company was over that line, the relief you may believe runs to November 2026 ran only to November 2025 and has already lapsed. That is the misreading that turns a planned purchase into an urgent one , what the exemption never covered walks through it, and what actually changes on 27 November 2026 takes the six obligations one at a time.

Choosing without a demo

• You cannot reach your transaction data without phoning a wholesaler. That is a continuing gap. A platform or a program with a data feed is the right purchase.
• Your data arrives fine, but an inspector asking for a dated SOP today would get nothing. That is a one-time gap, and a fixed-fee binder closes it.
• Both are true. Then both are worth buying, and the order matters less than starting before the date rather than after it.

Check which exemption track you are on, free, about a minute, and it stores nothing. Contact reaches a person.

The 27 November 2027 expiry and the 25-employee threshold are quoted from the FDA document DSCSA Exemptions from Certain Requirements Under Section 582 of the FD&C Act for Small Business Dispensers Until November 27, 2027, issued 6 August 2026, retrieved and re-verified 11 August 2026; it supersedes the 12 July 2024 letter previously cited here, at the same address. The competitor prices below were last retrieved on 7 August 2026 and were NOT re-checked today, so they carry that date rather than this one. The PRS company description is quoted from the prsrx.com home page rather than the DSCSA360 page, as retrieved 7 August 2026. The DSCSA360 program contents are quoted from prsrx.com/compliance/dscsa360 and the fee table from Attachment B of the service agreement at dscsa.prsrxnetwork.com, both as retrieved on 7 August 2026. The correction history for that price is on the record: it was quoted here as “as low as $66/month” from the product page, last confirmed there on 5 August 2026; on 7 August 2026 that page carried no dollar figure anywhere and the fee table on the portal read $115/month standard and $83/month discounted for a community pharmacy. The absence of published pricing at infinitrak.us, lspedia.com and advasur.com was re-checked on 7 August 2026, when all three /pricing routes returned 404 and no dollar figure appeared on any of the three sites. Oberheiden P.C. is quoted from federal-lawyer.com, and DispenserEDU’s self-description and its collaborating associations are taken from dscsa.pharmacy, both as retrieved on 7 August 2026; the seven associations appear on that page as logos rather than as text. Every company named here is independent, with no relationship to DoseTrace, and DoseTrace is not affiliated with DispenserEDU or any of the associations behind it. Their own sites are the authority on their own products and prices, if a number here disagrees with theirs, theirs is correct and we want to know. DoseTrace is not a law firm and nothing here is legal advice.